2023-07276. National Institute of Allergy and Infectious Diseases; Notice of Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council.

    The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious Diseases Council.

    Date: June 5, 2023.

    Open: 10:30 a.m. to 11:30 a.m.

    Agenda: Report of Institute Acting Director.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.

    Closed: 11:45 a.m. to 12:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.

    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.

    Date: June 5, 2023.

    Closed: 8:30 a.m. to 10:15 a.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, Conference Room A 45 Center Drive, Bethesda, MD 20892.

    Open: 1:00 p.m. to 4:00 p.m.

    Agenda: Report of the Division Director and Division Staff.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.

    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious Diseases Council Microbiology and Infectious Diseases Subcommittee.

    Date: June 5, 2023.

    Closed: 8:30 a.m. to 10:15 a.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.

    Open: 1:00 p.m. to 4:00 p.m.

    Agenda: Report of the Division Director and Division Staff.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.

    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious Diseases Council Immunology and Transplantation Subcommittee.

    Date: June 5, 2023.

    Closed: 8:30 a.m. to 10:15 a.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Natcher Building, Conference Room D, 45 Center Drive, Bethesda, MD 20892.

    Open: 1:00 p.m. to 4:00 p.m.

    Agenda: Report of the Division Director and Division Staff.

    Place: National Institutes of Health, Natcher Building, Conference Room D, 45 Center Drive, Bethesda, MD 20892.

    Contact Person: Kelly Y. Poe, Ph.D., Acting Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, poeky@mail.nih.gov.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice at least 10 days in advance of the meeting. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

    Information is also available on the Institute's/Center's home page: https://www.niaid.nih.gov/​about/​advisory-council, where an agenda and any additional information for the meeting will be posted when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    Dated: April 3, 2023.

    Tyeshia M. Roberson-Curtis,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2023–07276 Filed 4–6–23; 8:45 am]

    BILLING CODE 4140–01–P

Document Information

Published:
04/07/2023
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2023-07276
Dates:
June 5, 2023.
Pages:
20895-20895 (1 pages)
PDF File:
2023-07276.pdf